community
Our newest MATTER members are challenging conventional views of cancer treatment, helping reduce the effects of dry eye in North America and revolutionizing personal care monitoring.
Tieös Pharmaceuticals
Tieös Pharmaceuticals was formed in an operating room theater by two anesthesiologists who were frustrated with the current status quo of treatment outcomes for cancer. Dr. Arun Anand and Dr…
Read more
community
In this monthly blog post, members of the MATTER team highlight articles from across the web, and the occasional book or two, that cover some of the most relevant business and healthcare topics today.
Digital Transformation Is Not About Technology, Harvard Business Review
“Across various industries, we’re seeing the advent of ‘digital transformations’ — companies that are trying to bette…
Read more
community
Every day, innovators across the MATTER community are building new solutions that accelerate innovation, advance care and improve lives. Here’s a look into the most noteworthy headlines from the past few weeks.
AMOpportunities secures $2.2M to provide a world of talent
AMOpportunities, a startup that provides international medical students with a platform to find month-long clinical rotations…
Read more
community
Our newest MATTER members are on a mission to eliminate patient no-shows, help health systems manage vendor relationships and bring the vitamin industry to the next level.
Stitch Mix
Stitch Mix was started by Megan Wu and Justine Ly, medical students at the Loyola University Stritch School of Medicine. During their clinical experience, they became aware of the pervasive and expensive problem …
Read more
community
Every day, innovators across the MATTER community are building new solutions that accelerate innovation, advance care and improve lives. Here’s a look into the most noteworthy headlines from the past few weeks.
Third eyes on the [$7M] prize
Third Eye Health snagged $7.25 million in Series A financing. Third Eye is on a mission to prevent patient readmission to hospitals with better post-acute…
Read more